Rare Disease Genetic Testing Market Size, Share, Trends, Industry Analysis Report: By Technology, Speciality, Disease Type, End Use, and Region

Description

List of Tables

The global rare disease genetic testing market size is expected to reach USD 3,790.38 million by 2034, according to a new study by Polaris Market Research. The report "Rare Disease Genetic Testing Market Size, Share, Trends, Industry Analysis Report: By Technology, Speciality (Molecular Genetic Tests, Chromosomal Genetic Tests, and Biochemical Genetic Tests), Disease Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising rare disease genetic testing market demand is attributed to an increasing need for early and accurate diagnosis of rare genetic disorders. Advancements in next-generation sequencing (NGS) and other molecular diagnostic technologies have enhanced the efficiency and precision of genetic testing. In 2024, North America dominated the market, whereas the market in Asia Pacific is projected to witness the fastest growth, supported by rising investments in research and healthcare infrastructure. The growing prevalence of rare cardiovascular diseases, hereditary cancers, and metabolic disorders has further propelled the need for genetic testing. Moreover, companies are focusing on technological advancements, strategic collaborations, and regulatory approvals to expand their market presence globally. Additionally, the rising adoption of artificial intelligence (AI) in genomic research is streamlining disease detection, significantly impacting rare disease genetic testing market expansion.

Government initiatives and regulatory support are boosting innovation and encouraging the integration of genetic testing into routine healthcare. Further, the growing awareness among healthcare providers and patients regarding the benefits of genetic testing has led to wider adoption of rare disease genetic testing.

Europe's genetic testing market is experiencing moderate growth due to the rising prevalence of chronic diseases, an ageing population, and increasing demand for early disease detection and personalized medicine. The region's strong presence of global companies and research organizations, along with growing R&D activities, particularly in the UK, further fuels market growth. Moreover, government and industry efforts, including the European Commission's cancer initiatives and partnerships with companies such as Genetic Analysis AS and Blueprint Genetics, are driving rare disease genetic testing market growth.

Rare Disease Genetic Testing Market Report Highlights

In terms of technology, the PCR-based testing segment is expected to grow at the fastest rate during the forecast period, driven by its high sensitivity, rapid turnaround time, and increasing applications in diagnosing rare genetic disorders.
Based on end use, the diagnostic laboratories segment held the largest rare disease genetic testing market share due to the increasing demand for specialized genetic testing services, advanced diagnostic capabilities, and the growing adoption of next-generation sequencing (NGS) and PCR-based tests.
In 2024, North America accounted for the largest share of the rare disease genetic testing market revenue, driven by the increasing prevalence of genetic disorders, rising adoption of advanced diagnostic technologies, and strong presence of key market players.
The Asia Pacific rare disease genetic testing market is expected to witness the highest growth rate during the forecast period due to the growing prevalence of rare genetic disorders among the elderly generation.
A few of the global key market players are 3billion, Inc., Ambry Genetics, Baylor Genetics, Blueprint Genetics (Quest Diagnostics), Centogene N.V., Eurofins Scientific, GeneDx, LLC, Genomenon, Invitae Corporation, Revvity.

Polaris Market Research has segmented the rare disease genetic testing market report on the basis of technology, speciality, disease type, end use, and region:

By Technology Outlook (Revenue, USD Million, 2020-2034)

Next-Generation Sequencing
Array Technology
PCR-Based Testing
FISH
Sanger Sequencing
Karyotyping

By Speciality Outlook (Revenue, USD Million, 2020-2034)

Molecular Genetic Tests
Chromosomal Genetic Tests
Biochemical Genetic Tests

By Disease Type Outlook (Revenue, USD Million, 2020-2034)

Neurological Disease
Immunological Disorders
Hematology Diseases
Endocrine & Metabolism Diseases
Cancer
Musculoskeletal Disorders
Cardiovascular Disorders
Dermatology Disease
Others

By End Use Outlook (Revenue, USD Million, 2020-2034)

Research Laboratories & CROs
Hospitals & Clinics
Diagnostic Laboratories

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1772

Chapter 1. Overview and Scope

1.1 Research goal & scope
1.2 Market Scope

Chapter 2. Research Methodology Overview

2.1 Research Methodology
2.2 Research Scope and Assumptions
2.3 Information Procurement
- 2.3.1 Purchased Database
- 2.3.2 Internal Database
- 2.3.3 Secondary Sources
- 2.3.4 Third Party Perspective
- 2.3.5 Primary Research
2.4 Information Analysis
- 2.4.1 Data Analysis Models
2.5 Market Formulation and Data Visualization
2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

3.1 Market Overview
3.2 Market Segmentation
- 3.2.1 Market By Technology
- 3.2.2 Market By Specialty
- 3.2.3 Market By Disease Type
- 3.2.4 Market By End-use
- 3.2.5 Geographic Overview

Chapter 4. Rare Disease Genetic Testing Market Insights

4.1 Rare Disease Genetic Testing - Market Size and Growth Prospects
4.2 Rare Disease Genetic Testing Market Dynamics
- 4.2.1 Rare Disease Genetic Testing Market Driver and Opportunity Analysis
  - 4.2.1.1 Increasing Emphasis on Early Disease Detection and Prevention
  - 4.2.1.2 Growing Demand for Personalized Medicines
- 4.2.2 Rare Disease Genetic Testing Market Restraint/Challenges Analysis
  - 4.2.2.1 High Cost of Genetic Testing
  - 4.2.2.2 Social And Ethical Implications of Rare Genetic Testing
4.3 Rare Disease Genetic Testing Market- Porter's Five Forces Analysis
4.4 Rare Disease Genetic Testing Market- PESTLE Analysis
4.5 Rare Disease Genetic Testing Market- Key Industrial Trends
- 4.5.1 Increasing Application of Rare Genetic Testing in Oncology
4.6 Rare Disease Genetic Testing Market- COVID-19 Impact Analysis

Chapter 5. Rare Disease Genetic Testing Market Assessment By Technology

5.1 Introduction
5.2 Next-Generation Sequencing
- 5.2.1 Whole Exome
- 5.2.2 Whole Genome
5.3 Array Technology
5.4 PCR-based Testing
5.5 FISH (Fluorescent in situ hybridization)
5.6 Sanger Sequencing
5.7 Karyotyping

Chapter 6. Rare Disease Genetic Testing Market Assessment By Specialty

6.1 Introduction
6.2 Molecular Genetic Tests
6.3 Chromosomal Genetic Tests
6.4 Biochemical, Genetic Tests

Chapter 7. Rare Disease Genetic Testing Market Assessment By Disease Type

7.1 Introduction
7.2 Neurological Disease
7.3 Immunological Disorders
7.4 Hematology Diseases
7.5 Endocrine & Metabolism Diseases
7.6 Cancer
7.7 Musculoskeletal Disorders
7.8 Cardiovascular Disorders
7.9 Dermatology Disease
7.10 Others

Chapter 8. Rare Disease Genetic Testing Market Assessment By End-use

8.1 Introduction
8.2 Research Laboratories & Contract Research Organizations (Cros)
8.3 Hospitals & Clinics
8.4 Diagnostic Laboratories

Chapter 9. Rare Disease Genetic Testing Market Assessment by Geography

9.1 Introduction
9.2 NORTH AMERICA
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 EUROPE
- 9.3.1 Germany
- 9.3.2 France
- 9.3.3 Italy
- 9.3.4 U.K
- 9.3.5 Spain
- 9.3.6 Netherlands
- 9.3.7 Russia
- 9.3.8 Rest of Europe
9.4 ASIA-PACIFIC
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 Indonesia
- 9.4.5 South Korea
- 9.4.6 Malaysia
- 9.4.7 Rest of APAC
9.5 LATIN AMERICA
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Mexico
- 9.5.4 RoLATAM
9.6 MIDDLE EAST AND AFRICA
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Israel
- 9.6.5 Rest of Middle East & Africa

Chapter 10. Competitive Landscape

10.1 Product Development and Launches are the Best Adopted Strategy by the Companies
10.2 Product Launch
10.3 Acquisition/Agreement
10.4 Partnership & Collaboration

Chapter 11. Company Profiles

11.1 Centogene N.V.
- 11.1.1 Business Overview
- 11.1.2 Financial Snapshot
- 11.1.3 Product Benchmarking
- 11.1.4 Recent Developments
11.2 3billion, Inc.
- 11.2.1 Business Overview
- 11.2.2 Product Benchmarking
- 11.2.3 Recent Developments
11.3 Ambry Genetics.
- 11.3.1 Business Overview
- 11.3.2 Product Benchmarking
- 11.3.3 Recent Developments
11.4 GeneDx, LLC
- 11.4.1 Business Overview
- 11.4.2 Financial Snapshot
- 11.4.3 Product Benchmarking
- 11.4.4 Recent Developments
11.5 Blueprint Genetics (Quest Diagnostics)
- 11.5.1 Business Overview
- 11.5.2 Product Benchmarking
- 11.5.3 Recent Developments
11.6 Invitae Corporation.
- 11.6.1 Business Overview
- 11.6.2 Financial Snapshot
- 11.6.3 Product Benchmarking
- 11.6.4 Recent Developments
11.7 Baylor Genetics
- 11.7.1 Business Overview
- 11.7.2 Product Benchmarking
- 11.7.3 Recent Developments
11.8 Eurofins Scientific
- 11.8.1 Business Overview
- 11.8.2 Financial Snapshot
- 11.8.3 Product Benchmarking
- 11.8.4 Recent Developments
11.9 Genomenon
- 11.9.1 Business Overview
- 11.9.2 Product Benchmarking
- 11.9.3 Recent Developments
11.10 Revvity
- 11.10.1 Business Overview
- 11.10.2 Financial Snapshot
- 11.10.3 Product Benchmarking

Product Code: PM1772

List of Tables

Table 1 Global Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Table 2 Global Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Table 3 Global Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Table 4 Global Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Table 5 Global Rare Disease Genetic Testing Market Assessment, By Geography, 2020-2034 (USD Million)
Table 6 North America: Rare Disease Genetic Testing Market, by Country, 2020-2034 (USD Million)
Table 7 North America: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Table 8 North America: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Table 9 North America: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Table 10 North America: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Table 11 Europe: Rare Disease Genetic Testing Market, by Country, 2020-2034 (USD Million)
Table 12 Europe: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Table 13 Europe: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Table 14 Europe: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Table 15 Europe: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Table 16 APAC: Rare Disease Genetic Testing Market, by Country, 2020-2034 (USD Million)
Table 17 Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Table 18 Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Table 19 Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Table 20 Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Table 21 Latin America: Rare Disease Genetic Testing Market, by Country, 2020-2034 (USD Million)
Table 22 Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Table 23 Latin America: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Table 24 Latin America: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Table 25 Latin America: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Table 26 Middle East and Africa: Rare Disease Genetic Testing Market, by Country, 2020-2034 (USD Million)
Table 27 Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Table 28 Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Table 29 Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Table 30 Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)

List of Figures

Figure 1. Rare Disease Genetic Testing Market- Scope
Figure 2. Information Procurement
Figure 3. Primary Research Pattern
Figure 4. Primary research process
Figure 5. Market research approaches - Bottom Up Approach
Figure 6. Market research approaches - Top Down Approach
Figure 7. Market research approaches - Combined Approach
Figure 8. Rare Disease Genetic Testing - Market Overview 2019-2032 (USD Mn)
Figure 9. Rare Disease Genetic Testing - Market By Technology 2019-2032 (USD Mn)
Figure 10. Rare Disease Genetic Testing - Market By Specialty 2019-2032 (USD Mn)
Figure 11. Rare Disease Genetic Testing - Market By Disease Type 2019-2032 (USD Mn)
Figure 12. Rare Disease Genetic Testing - Market By End-use 2019-2032 (USD Mn)
Figure 13. Rare Disease Genetic Testing - Market By Region 2019-2032 (USD Mn)
Figure 14. Rare Disease Genetic Testing - Market Size and Growth Prospects (USD Mn)
Figure 15. Rare Disease Genetic Testing Market- Porter's Five Forces Analysis
Figure 16. Rare Disease Genetic Testing Market - PESTLE Analysis
Figure 17. Rare Disease Genetic Testing Market By Technology 2020-2034 (USD Million)
Figure 18. Global Rare Disease Genetic Testing Market - By Next-Generation Sequencing, 2020-2034 (USD Million)
Figure 19. Global Rare Disease Genetic Testing Market - By Whole Exome, 2020-2034 (USD Million)
Figure 20. Global Rare Disease Genetic Testing Market - By Whole Genome, 2020-2034 (USD Million)
Figure 21. Global Rare Disease Genetic Testing Market - By Services, 2020-2034 (USD Million)
Figure 22. Global Rare Disease Genetic Testing Market - By PCR-based Testing, 2020-2034 (USD Million)
Figure 23. Global Rare Disease Genetic Testing Market - By FISH, 2020-2034 (USD Million)
Figure 24. Global Rare Disease Genetic Testing Market - By Sanger Sequencing, 2020-2034 (USD Million)
Figure 25. Global Rare Disease Genetic Testing Market - By Karyotyping, 2020-2034 (USD Million)
Figure 26. Rare Disease Genetic Testing Market By Specialty 2020-2034 (USD Million)
Figure 27. Global Rare Disease Genetic Testing Market By Molecular Genetic Tests 2020-2034 (USD Million)
Figure 28. Global Rare Disease Genetic Testing Market By Chromosomal Genetic Tests 2020-2034 (USD Million)
Figure 29. Global Rare Disease Genetic Testing Market By Biochemical, Genetic Tests 2020-2034 (USD Million)
Figure 30. Global Rare Disease Genetic Testing Market By Disease Type 2019-2032
Figure 31. Global Rare Disease Genetic Testing Market - by Neurological Disease, 2020-2034 (USD Million)
Figure 32. Global Rare Disease Genetic Testing Market - by Immunological Disorders, 2020-2034 (USD Million)
Figure 33. Global Rare Disease Genetic Testing Market - by Hematology Diseases, 2020-2034 (USD Million)
Figure 34. Global Rare Disease Genetic Testing Market - by Endocrine & Metabolism Diseases, 2020-2034 (USD Million)
Figure 35. Global Rare Disease Genetic Testing Market - by Cancer, 2020-2034 (USD Million)
Figure 36. Global Rare Disease Genetic Testing Market - by Musculoskeletal Disorders, 2020-2034 (USD Million)
Figure 37. Global Rare Disease Genetic Testing Market - by Cardiovascular Disorders, 2020-2034 (USD Million)
Figure 38. Global Rare Disease Genetic Testing Market - by Dermatology Disease, 2020-2034 (USD Million)
Figure 39. Global Rare Disease Genetic Testing Market - by Others, 2020-2034 (USD Million)
Figure 40. Rare Disease Genetic Testing Market By End-use 2020-2034 (USD Million)
Figure 41. Global Rare Disease Genetic Testing Market By Research Laboratories & Cros 2020-2034 (USD Million)
Figure 42. Global Rare Disease Genetic Testing Market By Hospitals & Clinics 2020-2034 (USD Million)
Figure 43. Global Rare Disease Genetic Testing Market By Diagnostic Laboratories 2020-2034 (USD Million)
Figure 44. Global Rare Disease Genetic Testing Market Value, By Region, 2019 - 2032 (USD Mn)
Figure 45. Global Rare Disease Genetic Testing Market Value, By Technology, 2019 - 2032 (USD Mn)
Figure 46. Global Rare Disease Genetic Testing Market Value, By Specialty, 2019 - 2032 (USD Mn)
Figure 47. Global Rare Disease Genetic Testing Market Value, By Disease Type, 2019 - 2032 (USD Mn)
Figure 48. Global Rare Disease Genetic Testing Market Value, By End-use, 2019 - 2032 (USD Mn)
Figure 49. North America: Rare Disease Genetic Testing Market, By Country, 2020-2034 (USD Million)
Figure 50. North America: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 51. North America: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 52. North America: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 53. North America: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 54. U.S: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 55. U.S: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 56. U.S: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 57. U.S: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 58. U.S: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 59. Canada: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 60. Canada: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 61. Canada: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 62. Canada: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 63. Canada: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 64. Europe Rare Disease Genetic Testing Market Value, by Country, in USD Mn, 2019 - 2032
Figure 65. Europe: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 66. Europe: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 67. Europe: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 68. Europe: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 69. Germany: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 70. Germany: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 71. Germany: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 72. Germany: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 73. Germany: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 74. France: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 75. France: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 76. France: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 77. France: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 78. France: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 79. Italy: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 80. Italy: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 81. Italy: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 82. Italy: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 83. Italy: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 84. U.K: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 85. U.K.: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 86. U.K.: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 87. U.K.: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 88. U.K.: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 89. Spain: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 90. Spain: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 91. Spain: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 92. Spain: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 93. Spain: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 94. Netherlands: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 95. Netherlands: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 96. Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 97. Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 98. Netherlands: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 99. Russia: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 100. Russia: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 101. Russia: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 102. Russia: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 103. Russia: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 104. Rest of Europe: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 105. Rest of Europe: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 106. Rest of Europe: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 107. Rest of Europe: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 108. Rest of Europe: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 109. Asia Pacific Rare Disease Genetic Testing Market Value, by Country, 2020-2034 (USD Million)
Figure 110. Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 111. Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 112. Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 113. Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 114. China: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 115. China: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 116. China: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 117. China: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 118. China: Rare Disease Genetic Testing Market, By End-use , 2020-2034 (USD Million)
Figure 119. India: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 120. India: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 121. India: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 122. India: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 123. India: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 124. Japan: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 125. Japan: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 126. Japan: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 127. Japan: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 128. Japan: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 129. Indonesia: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 130. Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 131. Indonesia: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 132. Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 133. Indonesia: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 134. South Korea: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 135. South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 136. South Korea: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 137. South Korea: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 138. South Korea: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 139. Malaysia: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 140. Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 141. Malaysia: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 142. Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 143. Malaysia: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 144. Rest Of APAC: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 145. Rest of Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 146. Rest of Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 147. Rest of Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 148. Rest of Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 149. Latin America Rare Disease Genetic Testing Market Value, by Country, 2020-2034 (USD Million)
Figure 150. Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 151. Latin America: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 152. Latin America: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 153. Latin America: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 154. Brazil: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 155. Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 156. Brazil: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 157. Brazil: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 158. Brazil: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 159. Argentina: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 160. Argentina: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 161. Argentina: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 162. Argentina: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 163. Argentina: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 164. Mexico: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 165. Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 166. Mexico: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 167. Mexico: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 168. Mexico: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 169. RoLATAM: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 170. RoLATAM: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 171. RoLATAM: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 172. RoLATAM: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 173. RoLATAM: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 174. Middle East & Africa Rare Disease Genetic Testing Market Value, by Country, 2019-2032 (USD Million)
Figure 175. Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 176. Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 177. Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 178. Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 179. Saudi Arabia: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 180. Saudi Arabia: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 181. Saudi Arabia: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 182. Saudi Arabia: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 183. Saudi Arabia: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 184. South Africa: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 185. South Africa: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 186. South Africa: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 187. South Africa: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 188. South Africa: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 189. UAE: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 190. UAE: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 191. UAE: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 192. UAE: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 193. UAE: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 194. Israel: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 195. Israel: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 196. Israel: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 197. Israel: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 198. Israel: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 199. Rest of Middle East & Africa: Rare Disease Genetic Testing Market, 2020-2034 (USD Million)
Figure 200. Rest of Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2020-2034 (USD Million)
Figure 201. Rest of Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2020-2034 (USD Million)
Figure 202. Rest of Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2020-2034 (USD Million)
Figure 203. Rest of Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2020-2034 (USD Million)
Figure 204. Strategic Analysis - Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market Size, Share, Trends, Industry Analysis Report: By Technology, Speciality, Disease Type, End Use, and Region - Market Forecast, 2025-2034

Description

Table of Contents

List of Tables

Rare Disease Genetic Testing Market Report Highlights

Table of Contents

Chapter 1. Overview and Scope

Chapter 2. Research Methodology Overview

Chapter 3. Executive Summary

Chapter 4. Rare Disease Genetic Testing Market Insights

Chapter 5. Rare Disease Genetic Testing Market Assessment By Technology

Chapter 6. Rare Disease Genetic Testing Market Assessment By Specialty

Chapter 7. Rare Disease Genetic Testing Market Assessment By Disease Type

Chapter 8. Rare Disease Genetic Testing Market Assessment By End-use

Chapter 9. Rare Disease Genetic Testing Market Assessment by Geography

Chapter 10. Competitive Landscape

Chapter 11. Company Profiles

List of Tables

List of Figures